Safety, Effectiveness and Immunogenicity of heterologous mRNA-1273 Boost
South Africa
Nigel Garrett, Tarylee Reddy, Nonhlanhla Yende-Zuma, Azwidhwi Takalani, Kubashni Woeber, Annie Bodenstein, Phumeza Jonas, Imke Engelbrecht, Waasila Jassat, Harry Moultrie, Debbie Bradshaw, Ishen Seocharan, Jackline Odhiambo, Kentse Khuto, Simone I. Richardson, Millicent A. Omondi, Rofhiwa Nesamari,
Created on
April 29, 2024
Last modified
April 29, 2024
Page views
24428
Download
2
Documentation in PDF
Metadata
DDI/XML
JSON
- Data files
- SHERPA_Safetydata
drug_name_anti_hypertensive_3 (drug_name_anti_hypertensive_3)
Data file: SHERPA_Safetydata
Overview
Valid:
377
Invalid:
0
Type:
Discrete
Width:
34
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| AMLIODIPINE | 1 |
0.3%
|
|
| AMLOC | 2 |
0.5%
|
|
| AMLODIPINE | 4 |
1.1%
|
|
| AMLODIPINE 10MG | 2 |
0.5%
|
|
| AMLOPIDINE | 1 |
0.3%
|
|
| Adalat | 2 |
0.5%
|
|
| Alipto | 1 |
0.3%
|
|
| Amiloretic | 1 |
0.3%
|
|
| Amlodipine | 26 |
6.9%
|
|
| Amlodipine 5 mg | 1 |
0.3%
|
|
| Amlodopine | 2 |
0.5%
|
|
| Amodipine and Analapril | 1 |
0.3%
|
|
| Amylodipine | 2 |
0.5%
|
|
| Antenolol | 1 |
0.3%
|
|
| Aprin | 1 |
0.3%
|
|
| Artenal 5mg | 1 |
0.3%
|
|
| Aspirin | 3 |
0.8%
|
|
| Aspirin Teva | 1 |
0.3%
|
|
| Asprin 1/2 daily | 3 |
0.8%
|
|
| Atenelol | 3 |
0.8%
|
|
| Atenenol | 1 |
0.3%
|
|
| Atenolol | 16 |
4.2%
|
|
| Atenolol 50mg | 1 |
0.3%
|
|
| Atorvastatin | 1 |
0.3%
|
|
| BISOPROLOL | 1 |
0.3%
|
|
| Bezafibrate 400 mg | 1 |
0.3%
|
|
| Captopril | 1 |
0.3%
|
|
| Carloc | 1 |
0.3%
|
|
| Carvedilol | 1 |
0.3%
|
|
| Cliplauasc 10mg 2017 | 1 |
0.3%
|
|
| Dispirin | 1 |
0.3%
|
|
| Disprin 1/2 daily | 1 |
0.3%
|
|
| ENALAPRIL | 5 |
1.3%
|
|
| ENLAPRIL | 2 |
0.5%
|
|
| ENNALPRIL | 1 |
0.3%
|
|
| Ecotrin | 1 |
0.3%
|
|
| Enalapril | 36 |
9.5%
|
|
| Enalapril 10 mg | 2 |
0.5%
|
|
| Enalapril 20 mg daily | 1 |
0.3%
|
|
| Enalipril | 1 |
0.3%
|
|
| Envas | 1 |
0.3%
|
|
| FUROSEMIDE | 1 |
0.3%
|
|
| Farxiga | 1 |
0.3%
|
|
| Fexofenadine HCL | 1 |
0.3%
|
|
| Forxiga | 1 |
0.3%
|
|
| Furobe | 1 |
0.3%
|
|
| Furosemide | 3 |
0.8%
|
|
| Furosimide 40mg/d | 1 |
0.3%
|
|
| HCIZ | 1 |
0.3%
|
|
| HCTZ | 1 |
0.3%
|
|
| Hydrochlorothiazide | 3 |
0.8%
|
|
| Hydrochlorothiazide 12.5mg | 1 |
0.3%
|
|
| Hydrochlorothiazme | 1 |
0.3%
|
|
| Indapamide | 1 |
0.3%
|
|
| Indepamide 2,5mg po od | 1 |
0.3%
|
|
| Isordil | 1 |
0.3%
|
|
| Laxis 40mg | 1 |
0.3%
|
|
| Lorstan | 1 |
0.3%
|
|
| Losartan | 8 |
2.1%
|
|
| Losarton | 1 |
0.3%
|
|
| N/A | 61 |
16.2%
|
|
| N\A | 89 |
23.6%
|
|
| PHARMAPRESS | 1 |
0.3%
|
|
| Perindopril | 1 |
0.3%
|
|
| Petergen | 1 |
0.3%
|
|
| Pharmapress | 6 |
1.6%
|
|
| Premium Plus | 1 |
0.3%
|
|
| RIDAQ | 2 |
0.5%
|
|
| Ridag 25mg | 1 |
0.3%
|
|
| Ridaq | 5 |
1.3%
|
|
| SPIRACTIN | 1 |
0.3%
|
|
| Simvastatin | 2 |
0.5%
|
|
| Simvastatin (Hypercholesterolaemia | 2 |
0.5%
|
|
| Simvastatin 10mg | 1 |
0.3%
|
|
| Sinopren | 1 |
0.3%
|
|
| Spiractin | 1 |
0.3%
|
|
| Spironolactone | 1 |
0.3%
|
|
| Symvastatine 5mg npcte | 1 |
0.3%
|
|
| Unat | 1 |
0.3%
|
|
| Unknown | 2 |
0.5%
|
|
| VERAPAMIL | 1 |
0.3%
|
|
| Ventolin | 1 |
0.3%
|
|
| Zartan | 1 |
0.3%
|
|
| ZildemSR | 1 |
0.3%
|
|
| Zocor | 1 |
0.3%
|
|
| adalat | 1 |
0.3%
|
|
| amlodepine | 1 |
0.3%
|
|
| amlodipine | 4 |
1.1%
|
|
| amlodipine 10mg daily | 1 |
0.3%
|
|
| carvedilol | 1 |
0.3%
|
|
| cipalat retard | 1 |
0.3%
|
|
| disprin 300mg | 1 |
0.3%
|
|
| enalapril | 2 |
0.5%
|
|
| fedaloc 30mg sr nocte | 1 |
0.3%
|
|
| hydrochlorothiazide | 2 |
0.5%
|
|
| indipimide | 1 |
0.3%
|
|
| lasix | 1 |
0.3%
|
|
| perindopril | 1 |
0.3%
|
|
| pharmapress | 1 |
0.3%
|
|
| ridaq | 1 |
0.3%
|
|
| simastatin | 1 |
0.3%
|
|
| simvastatin | 2 |
0.5%
|
|
| triphasil | 1 |
0.3%
|
|
| valsartan | 1 |
0.3%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.